The packaging industry started 2024 on a weak note, facing subdued demand as customers curtailed spending amid an inflationary backdrop and high interest rates. Supply-chain disruptions and elevated costs added to the difficulties. To maintain margins, companies implemented cost-cutting measures and pricing strategies. However, the situation improved later in the year, with companies reporting volume recovery as pressures on customers abated. Despite the challenging backdrop, stocks like Packaging Corporati ...

The Zacks Containers -  Paper and Packaging industry has been facing weak demand due to lower consumer spending amid an inflationary backdrop. Pricing actions implemented by the industry players will help offset the impacts of supply-chain disruptions and elevated costs. The industry will eventually gain support from rising e-commerce activities, and solid demand for sustainable and eco-friendly packaging options due to increasing environmental concerns.Companies like Packaging Corporation of America (PKG) ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.It also includes access to the Zacks Style Scores. ...

AptarGroup, Inc. (ATR) reported third-quarter 2024 adjusted earnings per share (EPS) of $1.49, beating the Zacks Consensus Estimate of $1.43. The bottom line increased 6% year over year from $1.40 (including comparable exchange rates). On a reported basis, EPS was $1.48 compared with the year-ago quarter's $1.26. Total revenues increased 1.8% year over year to $909 million in the reported quarter. However, the reported figure missed the Zacks Consensus Estimate of $932 million. Core sales, excluding currenc ...

Aptar ∠ Q3 2024 Results Stephan Tanda, President & CEO and Bob Kuhn, Executive Vice President and CFO October 25, 2024 Forward Looking Statements & Non-GAAP Financial Measures This presentation includes forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on management's beliefs and assumptions in light of information currently available to manag ...

Financial Data and Key Metrics Changes - For Q3 2024, Aptar achieved core sales growth of 2% and delivered adjusted EPS of $1.49 per share, a 6% increase over the prior year's quarter [3][15] - Adjusted EPS grew by 15% for the first nine months of the year, with expectations for double-digit growth for the full year [3] - Adjusted EBITDA margin was at the top end of the long-term range at 23% [3] - Free cash flow more than doubled to $255 million for the nine months ended September 30 compared to $124 million in the prior year [15] Business Line Data and Key Metrics Changes - Pharma segment's core sales increased by 7%, driven by volume growth in proprietary drug delivery systems and active material science solutions [16] - Closures segment reported core sales growth of 4%, returning to its long-term target range [20] - Beauty segment's core sales decreased by 6%, attributed to lower tooling sales and a less favorable product mix [18] Market Data and Key Metrics Changes - Core sales for the food market within Closures increased by 10%, while beverage core sales increased by 1% [20] - Personal care market core sales increased by 5%, driven by demand for body lotions and hair care products, mainly in Europe and North America [19] - Home Care core sales increased by 18%, primarily due to rebounding sales in North America [19] Company Strategy and Development Direction - The company is focusing on organic growth for its Pharma business while exploring potential acquisitions to strengthen market position [7][8] - Recent acquisition of technology assets from SipNose enhances Aptar's capabilities in intranasal delivery platforms [8] - The company is investing in higher value components and services in its injectables business to meet growing market needs [9] Management's Comments on Operating Environment and Future Outlook - Management anticipates continued growth in the Pharma segment, especially for proprietary drug delivery systems [24] - The Beauty segment is facing a tough macro environment but is expected to recover as North America shows signs of improvement [25] - The company expects fourth quarter adjusted EPS to be in the range of $1.22 to $1.30 per share, with full year adjusted EPS projected between $5.34 to $5.42 [22] Other Important Information - Aptar was recognized as one of the World's Best Companies of 2024 by TIME, reflecting its commitment to employee satisfaction and transparency in ESG reporting [13] - The company recently closed a joint venture with a pump manufacturer in China, acquiring a 40% stake to enhance local supply chain capabilities [12] Q&A Session Summary Question: What needs to happen for Beauty to reach a 15% margin in 2025? - Management indicated that Beauty is progressing, but growth in China is slower than expected, affecting overall performance [28][29] Question: Is the new product cadence in Pharma higher than typical? - Management expressed confidence in continued growth within the Pharma segment, indicating that new product introductions are contributing to this growth [33][34] Question: What is the sales cycle for beauty products? - The sales cycle varies, with Western clients typically taking 18 to 36 months, while other markets may see quicker turnarounds [44] Question: How is the injectables business expected to perform moving forward? - Management remains bullish on the injectables business, anticipating high single-digit to low double-digit growth [47]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 1-11846 AptarGroup, Inc. Delaware 36-3853103 (State of Incorporation) (I.R.S. Employer Identification No.) 265 EXCHANGE D ...

AptarGroup (ATR) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.39 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 4.20%. A quarter ago, it was expected that this maker of consumer-product dispensing systems would post earnings of $1.36 per share when it actually produced earnings of $1.37, delivering a surprise of 0.74%.Over the las ...

Financial Performance - Reported sales increased by 2% to $909 million in Q3 2024, compared to $893 million in the prior year[4] - Net income for the quarter was $100 million, reflecting a 19% increase year-over-year[1] - Adjusted EBITDA rose by 8% to $208 million, achieving an adjusted EBITDA margin of 23%[3] - For the first nine months of 2024, reported sales increased by 3% to $2.73 billion, with core sales also up by 3%[8] - Earnings per share for the first nine months were $4.05, a 22% increase from $3.32 in the prior year[10] - Net sales for Q3 2024 reached $909.3 million, a 1.5% increase from $893.0 million in Q3 2023[21] - Operating income for Q3 2024 was $138.3 million, up 15.9% from $119.3 million in Q3 2023[21] - Basic earnings per share for Q3 2024 increased to $1.51, up from $1.28 in Q3 2023, reflecting a 17.9% growth[21] - Adjusted EBITDA margin for Q3 2024 was 22.9%, compared to 21.5% in Q3 2023, indicating improved operational efficiency[26] - Net sales for the nine months ended September 30, 2024, were $2.73 billion, a 3.2% increase from $2.65 billion in the same period of 2023[21] Segment Performance - The Pharma segment reported sales growth of 8% and core sales growth of 7%, driven by strong demand for proprietary drug delivery systems[5] - The Closures segment achieved a 3% increase in reported sales and a 4% increase in core sales, primarily due to demand in the food market[7] - The Beauty segment saw a reported sales decline of 7%, with core sales down 6% due to lower tooling sales and challenging comparisons from the prior year[6] Shareholder Returns - Aptar's Board authorized a $500 million share repurchase program and declared a quarterly cash dividend of $0.45 per share[12] Cash Flow and Investments - Free cash flow for the three months ended September 30, 2024, was $162,712,000, compared to $97,214,000 for the same period in 2023, indicating a significant increase of 67.2%[35] - The company reported net cash provided by operations of $229,262,000 for the three months ended September 30, 2024, compared to $173,401,000 for the same period in 2023, an increase of 32.2%[35] Future Outlook - The company expects Q4 2024 earnings per share to be in the range of $1.22 to $1.30, indicating a double-digit increase over full year 2023[11] - The company expects adjusted net income attributable to AptarGroup for the fourth quarter of 2024 to be in the range of $1.22 to $1.30 per diluted share, compared to $1.24 for the fourth quarter of 2023[37] Restructuring and Costs - The company reported a restructuring initiative cost of $3.9 million in Q3 2024, down from $6.2 million in Q3 2023[21] - Restructuring initiatives incurred costs of $9,659, with additional transaction costs related to acquisitions amounting to $140[30] - Restructuring initiatives resulted in costs of $3,864,000 for the three months ended September 30, 2024, down from $6,161,000 in the same period of 2023, indicating a reduction of 37.3%[33] Assets and Liabilities - Total assets as of September 30, 2024, were $4.63 billion, an increase from $4.45 billion at the end of 2023[23] - The company’s total liabilities increased to $2.54 billion as of September 30, 2024, from $2.31 billion at the end of 2023[24] Taxation - The provision for income taxes for the three months ended September 30, 2024, was $31,209,000, compared to $25,751,000 for the same period in 2023, reflecting a year-over-year increase of 21.3%[33]

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn't easy.The trend often reverses before exiting the trade, leading to a short-term capital loss for investors. So, for a profitable trade, one should confirm factors such as sound fundamentals, positive earnings estimate revisions, etc. that could keep the momentum in the stock aliv ...